Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Mytrex Health Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Mytrex Health Technologies's highest Yield on Cost was 35.84. The lowest was 0.12. And the median was 1.51.
ROCO:4431's 5-Year Yield-on-Cost % is not ranked *
in the Industrial Products industry.
Industry Median: 1.905 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Mytrex Health Technologies (ROCO:4431) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Mytrex Health Technologies 5-Year Yield-on-Cost % Related Terms
ROCO:4431 vs GEV, ETN, PH: 5-Year Yield-on-Cost % Comparison
For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mytrex Health Technologies 5-Year Yield-on-Cost % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Mytrex Health Technologies's 5-Year Yield-on-Cost % falls into.
Mytrex Health Technologies 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Mytrex Health Technologies (ROCO:4431) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mytrex Health Technologies and its competitors. Over the past decade, Mytrex Health Technologies' 5-Year Yield-on-Cost % has ranged from 0.12 to 35.84. According to the industry distribution chart, Mytrex Health Technologies ranks #999999 out of 1896 companies in the Industrial Products industry.
Is Mytrex Health Technologies' 5-Year Yield-on-Cost % too high?
Mytrex Health Technologies' current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 35.84. Based on the distribution chart, Mytrex Health Technologies ranks #999999 out of 1896 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Mytrex Health Technologies has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' 5-Year Yield-on-Cost % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Mytrex Health Technologies ranks #999999 out of 1896 companies for 5-Year Yield-on-Cost %. This places Mytrex Health Technologies in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.91. Historically, Mytrex Health Technologies' own 5-Year Yield-on-Cost % has ranged from 0.12 to 35.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Industrial Products company?
The median 5-Year Yield-on-Cost % among Industrial Products companies is 1.91, based on 1,896 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Mytrex Health Technologies and its competitors. For the Industrial Products industry, the median 5-Year Yield-on-Cost % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mytrex Health Technologies's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$28.48, compared to a current price of NT$18.75 — trading 34.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Mytrex Health Technologies' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?
Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued.
The current stock price of NT$18.75 is trading 34.2% below its estimated GF Value™ of NT$28.48.
GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4431:
5-Year Yield-on-Cost %: 0.00
GF Value™: NT$28.48 vs. price of NT$18.75 (34.2% below fair value)
No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
68GF Score
Get the complete analysis for ROCO:4431
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4431 has been successfully added to your 
